Paper Details
- Home
- Paper Details
Effects of Nephrolithiasis on Serum DNase (Deoxyribonuclease I and II) Activity and E3 SUMO-Protein Ligase NSE2 (NSMCE2) in Malaysian Individuals.
Author: GhazaliHamid, MehdeAtheer Awad, MehdiWesen Adel, RahmanAzlina Abd, RausRaha Ahmed, YusofFaridah
Original Abstract of the Article :
Nephrolithiasis is one of the most common disorders of the urinary tract. The aim of this study was to examine a possible relationship between DNase I/II activity and E3 SUMO-protein ligase NSE2 in the sera of nephrolithiasis patients to evaluate the possibility of a new biomarker for evaluating kid...See full text at original site
Dr.Camel's Paper Summary Blogラクダ博士について
ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。
* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。
引用元:
https://pubmed.ncbi.nlm.nih.gov/26464253
データ提供:米国国立医学図書館(NLM)
Exploring Potential Biomarkers for Nephrolithiasis
Nephrolithiasis, a common condition affecting the [urinary tract], can lead to [kidney damage]. This study explores the potential of [DNase I/II activity and E3 SUMO-protein ligase NSE2] as [biomarkers] for evaluating kidney damage in patients with nephrolithiasis.
Potential Biomarkers for Kidney Damage
The study examined the levels of these [enzymes] in the [sera] of patients with nephrolithiasis, investigating their potential association with [kidney damage]. While the study results require further investigation, they suggest that these [enzymes] could serve as valuable [biomarkers] for assessing the severity of kidney damage in nephrolithiasis patients.
Uncovering New Tools for Kidney Health
Dr. Camel sees this research as a step towards a clearer understanding of the mechanisms underlying [kidney damage] in nephrolithiasis. Just as a camel uses its keen senses to navigate the desert, researchers are using their knowledge to uncover new tools for diagnosing and treating kidney disease.
Dr. Camel's Conclusion
This study sheds light on potential biomarkers for nephrolithiasis, opening new doors for early diagnosis and targeted treatment. Further research is needed to validate these findings and determine their clinical utility.
Date :
- Date Completed 2016-02-25
- Date Revised 2018-06-08
Further Info :
Related Literature
English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.